| Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets DP Misra, V Agarwal, AY Gasparyan, O Zimba Clinical rheumatology 39 (7), 2055-2062, 2020 | 336 | 2020 |
| Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad S Ahmed, O Zimba, AY Gasparyan Clinical Rheumatology 39, 2529-2543, 2020 | 285 | 2020 |
| Information and misinformation on COVID-19: a cross-sectional survey study L Gupta, AY Gasparyan, DP Misra, V Agarwal, O Zimba, M Yessirkepov Journal of Korean medical science 35 (27), 2020 | 171 | 2020 |
| COVID-19 and the clinical course of rheumatic manifestations S Ahmed, O Zimba, AY Gasparyan Clinical rheumatology 40, 2611-2619, 2021 | 129 | 2021 |
| Reporting survey based studies—a primer for authors PS Gaur, O Zimba, V Agarwal, L Gupta J Korean Med Sci 35 (45), e398, 2020 | 116 | 2020 |
| Social media for research, education and practice in rheumatology O Zimba, O Radchenko, L Strilchuk Rheumatology international 40 (2), 183-190, 2020 | 84 | 2020 |
| Clinical course and outcomes of 3,060 patients with coronavirus disease 2019 in Korea, January–May 2020 HK Sung, JY Kim, J Heo, H Seo, Y soo Jang, H Kim, BR Koh, N Jo, HS Oh, ... Journal of Korean medical science 35 (30), 2020 | 70 | 2020 |
| Perspectives of immune therapy in coronavirus disease 2019 AY Gasparyan, DP Misra, M Yessirkepov, O Zimba Journal of Korean Medical Science 35 (18), 2020 | 69 | 2020 |
| Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic S Ahmed, AY Gasparyan, O Zimba Rheumatology International 41 (2), 243-256, 2021 | 66 | 2021 |
| Moving towards online rheumatology education in the era of COVID-19 S Ahmed, O Zimba, AY Gasparyan Clinical Rheumatology 39, 3215-3222, 2020 | 59 | 2020 |
| Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates DP Misra, AY Gasparyan, O Zimba Rheumatology international 40 (11), 1741-1751, 2020 | 55 | 2020 |
| Plagiarism detection and prevention: a primer for researchers O Zimba, A Gasparyan Reumatologia/Rheumatology 59 (3), 132-137, 2021 | 47 | 2021 |
| Social media platforms: a primer for researchers O Zimba, AY Gasparyan Reumatologia/Rheumatology 59 (2), 68-72, 2021 | 37 | 2021 |
| COVID‐19 vaccination in autoimmune diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies A Gil‐Vila, N Ravichandran, A Selva‐O'Callaghan, P Sen, A Nune, ... Muscle & nerve 66 (4), 426-437, 2022 | 35 | 2022 |
| Statistical data presentation: a primer for rheumatology researchers DP Misra, O Zimba, AY Gasparyan Rheumatology International 41 (1), 43-55, 2021 | 35 | 2021 |
| Mechanisms of thrombosis in ANCA-associated vasculitis DP Misra, KN Thomas, AY Gasparyan, O Zimba Clinical rheumatology 40 (12), 4807-4815, 2021 | 34 | 2021 |
| Reactive arthritis before and after the onset of the COVID-19 pandemic D Bekaryssova, M Yessirkepov, O Zimba, AY Gasparyan, S Ahmed Clinical rheumatology 41 (6), 1641-1652, 2022 | 30 | 2022 |
| Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management P Mehta, AY Gasparyan, O Zimba, GD Kitas Clinical Rheumatology 41 (9), 2893-2910, 2022 | 28 | 2022 |
| Plagiarism in non-anglophone countries: a cross-sectional survey of researchers and journal editors L Gupta, J Tariq, M Yessirkepov, O Zimba, DP Misra, V Agarwal, ... Journal of Korean Medical Science 36 (39), 2021 | 26 | 2021 |
| Scholarly publishing and journal targeting in the time of the Coronavirus Disease 2019 (COVID-19) pandemic: a cross-sectional survey of rheumatologists and other specialists L Gupta, AY Gasparyan, O Zimba, DP Misra Rheumatology international 40 (12), 2023-2030, 2020 | 23 | 2020 |
Заремба Євгенія ХомівнаЛьвівський національний медичний університет імені Данила Галицького在 meduniv.lviv.ua 的电子邮件经过验证
